Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
French Innovative Leukemia Organization
Homepage:
filo-leukemia.org
Alternate names:
French Innovative Leukemia Organisation,
Groupe FILO
ROR:
04ryt1t28
OpenAlex ID:
I4405267860
A revised international prognostic score system for Waldenström’s macroglobulinemia
2019
·
Efstathios Kastritis
, Pierre Morel
, et al.
·
Leukemia
·
118
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
2017
·
Anne-Sophie Chretien
, Cyril Fauriat
, et al.
·
Frontiers in Immunology
·
75
PDF
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML
2017
·
Anne-Sophie Chretien
, Raynier Devillier
, et al.
·
OncoImmunology
·
65
PDF
Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia
2016
·
Delphine Ohayon
, Alessia De Chiara
, et al.
·
Scientific Reports
·
62
PDF
NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
2017
·
Anne-Sophie Chretien
, Cyril Fauriat
, et al.
·
Oncotarget
·
55
PDF
n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation
2018
·
Frédéric Picou
, Christelle Debeissat
, et al.
·
Pharmacological Research
·
50
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study
2021
·
Emmanuel Bachy
, Roch Houot
, et al.
·
Blood
·
38
Rituximab maintenance versus observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): an open-label, randomised phase 3 study
2017
·
Caroline Dartigeas
, Eric Van Den Neste
, et al.
·
The Lancet Haematology
·
38
Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group
2022
·
Romain Guieze
, Loic Ysebaert
, et al.
·
Blood
·
17
Intermediate-Dose Cytarabine as Postinduction AML Therapy
2025
·
Mathilde Hunault
, Cécile Pautas
, et al.
·
NEJM Evidence
·
16
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
2024
·
Romain Guièze
, Loïc Ysebaert
, et al.
·
Nature Communications
·
14
PDF
Midostaurin shapes macroclonal and microclonal evolution of FLT3 -mutated acute myeloid leukemia
2024
·
Romane Joudinaud
, Augustin Boudry
, et al.
·
Blood Advances
·
12
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
2020
·
Laetitia Largeaud
, Pascale Cornillet-Lefebvre
, et al.
·
Leukemia
·
11
PDF
Blinatumomab for Patients with Richter's Syndrome: A Multicenter Phase 2 Trial from the Filo Group
2021
·
Romain Guieze
, Loic Ysebaert
, et al.
·
Blood
·
9
Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia
2020
·
Sarah Huet
, Anne Bouvard
, et al.
·
Leukemia
·
6
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)
2025
·
Sarah Bertoli
, Emilie Bérard
, et al.
·
Haematologica
·
4
PDF
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia
2024
·
Cécile Tomowiak
, Stéphanie Poulain
, et al.
·
Annals of Hematology
·
4
PDF
Prognostic impact of genetic abnormalities in 536 first‐line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV‐mutated subgroups (a FILO study)
2024
·
Florence Nguyen‐Khac
, Marine Baron
, et al.
·
British Journal of Haematology
·
4
PDF
Una edición crítica del soneto "Voto a Diós" de cervantes (*)
2003
·
José Solis de los Santos
·
Philologia hispalensis
·
4
PDF
RIC Allogeneic Stem Cell Transplantation for High Risk CLL Followed By Preemptive MRD-Based Immunointervention - Intermediate Results from the Phase II ICLL03 Ricac-Pmm Trial (FILO & SFGM-TC French intergroup)
2015
·
Olivier Tournilhac
, Magali Le Garff-Tavernier
, et al.
·
Blood
·
3
Blinatumomab after R-CHOP Debulking Therapy for Patients with Richter Transformation: Preliminary Results of the Multicenter Phase 2 Blinart Trial from the Filo Group
2020
·
Romain Guieze
, Loic Ysebaert
, et al.
·
Blood
·
2
Pf393 a Randomised Joint Australasian (allg) and French (filo) Study of Lenalidomide Consolidation in Patients With Residual Cll After Front‐line Treatment With Fc/fcr (the Cll6 Trial)
2019
·
D. Gottlieb
, T. Aurran‐Schleinitz
, et al.
·
HemaSphere
·
2
Real life study of ivosidenib in either monotherapy or combined with azacytidine for first line mutant IDH1 AML: A study from the french AML intergroup ALFA/filo
2025
·
Pierre Peterlin
, Mael Heiblig
, et al.
·
Blood
·
1
PDF
Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
2019
·
Anne-Sophie Chretien
, Cyril Fauriat
, et al.
·
Oncotarget
·
1
PDF
La figura literària del clergue en la poesia de Ramon de Cornet.
2012
·
Marina Navàs Farré
·
Mot so razo
·
1
PDF
Show more works
View as search
Works count:
35
Citation count:
1,551
Year
Topic
Type
